Clinical trials
Active, not recruiting Phase 1 Lymphoma, Follicular trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
30 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2013 | 2 |
| 2014 | 2 |
| 2016 | 1 |
| 2017 | 3 |
| 2018 | 1 |
| 2019 | 4 |
| 2020 | 4 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 8 |
| 2024 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 30 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| City of Hope Medical Center | 5 |
| National Cancer Institute (NCI) | 4 |
| AbbVie | 3 |
| AstraZeneca | 1 |
| Beth Christian | 1 |
| Bio-Path Holdings, Inc. | 1 |
| Bristol-Myers Squibb | 1 |
| Dana-Farber Cancer Institute | 1 |
| Dr. Eliza Hawkes | 1 |
| Jonsson Comprehensive Cancer Center | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphoma, Follicular | 30 |
| Lymphoma, Large B-Cell, Diffuse | 18 |
| Lymphoma, Mantle-Cell | 13 |
| Lymphoma, B-Cell, Marginal Zone | 12 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 9 |
| Lymphoma, B-Cell | 9 |
| Lymphoma, Non-Hodgkin | 8 |
| Waldenstrom Macroglobulinemia | 4 |
| Burkitt Lymphoma | 3 |
| Lymphoma, T-Cell, Cutaneous | 3 |
Trials
Showing 1 to 25 of 30. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.